Skip to content
  • English
  • Español
  • About us
    • The company​
    • Facilities
    • Values
    • Leadership team​
  • Biopharmaceutical
    development​
    • Pipeline
    • R&D​
    • Partnerships
  • CDMO services​
    • Capabilities
    • Services
    • Expertise
    • Case studies​
  • Media center​
    • Press releases​
    • Blog
    • Videos
  • Contact
    • Get in touch​
    • Find our sites​
    • Join us​
  • About us
    • The company​
    • Facilities
    • Values
    • Leadership team​
  • Biopharmaceutical
    development​
    • Pipeline
    • R&D​
    • Partnerships
  • CDMO services​
    • Capabilities
    • Services
    • Expertise
    • Case studies​
  • Media center​
    • Press releases​
    • Blog
    • Videos
  • Contact
    • Get in touch​
    • Find our sites​
    • Join us​
  • About us
    • The company​
    • Facilities
    • Values
    • Leadership team​
  • Biopharmaceutical
    development​
    • Pipeline
    • R&D​
    • Partnerships
  • CDMO services​
    • Capabilities
    • Services
    • Expertise
    • Case studies​
  • Media center​
    • Press releases​
    • Blog
    • Videos
  • Contact
    • Get in touch​
    • Find our sites​
    • Join us​
What’s next? Meet us at...

Bio 2021

January 22, 2021
  • Meet us at BIO, to be held 14-17 June. 2021.

Share this post

Related posts

adriana.polo2025-07-02T15:00:56+02:00

mAbxience announces European Commission approval of denosumab biosimilars

adriana.polo2025-07-02T15:00:56+02:00July 2, 2025|

Miguel Martínez-Cava2025-07-02T12:29:30+02:00

mAbxience and Corapharm Announce Strategic Licensing Agreement for Biosimilar Candidate in Southeast Europe

Miguel Martínez-Cava2025-07-02T12:29:30+02:00June 2, 2025|

Miguel Martínez-Cava2025-07-02T12:28:58+02:00

mAbxience and Abiogen Pharma Announce Strategic Licensing Agreement for Biosimilar Candidate in Italy

Miguel Martínez-Cava2025-07-02T12:28:58+02:00May 26, 2025|

VIEW ALL

LinkedIn

FOLLOW US
SUBSCRIBE
  • Terms of use
  • Privacy & Terms
  • Cookies policy
  • Code of conduct and compliance
  • Non-Financial Information Statement

Copyright 2025 mAbxience, creating a strong value in biosimilars and CDMO platform | Powered by Scienseed

Page load link
{Le informamos que mAbxience utiliza cookies para asegurar que le damos la mejor experiencia en nuestra web. Si continúa usando este sitio, asumiremos que está de acuerdo con ello.}AceptarNoPolítica de privacidad
Puedes revocar tu consentimiento en cualquier momento usando el botón de revocación del consentimiento.Revocar el consentimiento
Go to Top